METHODS AND SYSTEMS FOR MODIFYING BIOACTIVE AGENT USE

• US 20130289360A1
• Filed: 04/05/2013
• Published: 10/31/2013
• Est. Priority Date: 04/24/2008
• Status: Active Grant

• Current Assignee: Harvest Bio LLC
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Hyde, Roderick A., Ishikawa, Muriel Y., Leuthardt, Eric C., Levien, Royce A., Lord, Robert W., Malamud, Mark A., Sweeney, Elizabeth A., Wood, Lowell L. Jr., Wood, Victoria Y.H.
• Granted Patent: US 9,504,788 B2
• Time in Patent Office: Days
• US Class Current: 600/300
• CPC Class Codes: A61B 5/024 Detecting, measuring or recording pulse rate or heart rate A61B5/0205, A61B5/021 take precedence
• CPC Class Codes: A61B 5/05 Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves impedance plethysmography A61B5/0295; measuring movement of the entire body or parts thereof A61B5/11; detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof A61B5/24
• CPC Class Codes: A61B 5/08 Detecting, measuring or recording devices for evaluating the respiratory organs A61B5/0205 takes precedence
• CPC Class Codes: A61B 5/16 Devices for psychotechnics using teaching or educational appliances G09B1/00 - G09B7/00; Testing reaction times ; Devices for evaluating the psychological state
• CPC Class Codes: A61B 5/24 Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/415 the glands, e.g. tonsils, adenoids or thymus
• CPC Class Codes: A61B 5/416 the spleen
• CPC Class Codes: A61B 5/418 lymph vessels, ducts or nodes
• CPC Class Codes: A61B 5/4266 sweat secretion
• CPC Class Codes: A61B 5/48 Other medical applications
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61M 2205/50 with microprocessors or computers
• CPC Class Codes: A61M 2205/502 User interfaces, e.g. screens or keyboards
• CPC Class Codes: A61M 2205/52 with memories providing a history of measured variating parameters of apparatus or patient
• CPC Class Codes: A61M 2205/581 by audible feedback
• CPC Class Codes: A61M 2230/04 Heartbeat characteristics, e.g. ECG, blood pressure modulation
• CPC Class Codes: A61M 2230/10 Electroencephalographic signals
• CPC Class Codes: A61M 2230/30 Blood pressure A61M2230/04 takes precedence
• CPC Class Codes: A61M 2230/65 Impedance, e.g. conductivity, capacity
• CPC Class Codes: A61M 5/1723 : using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G06F 16/24575 : using context
• CPC Class Codes: G06F 3/011 : Arrangements for interaction with the human body, e.g. for user immersion in virtual reality blind teaching G09B21/00
• CPC Class Codes: G16H 20/10 : relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 40/20 : for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms

Abstract

Methods, computer program products, and systems are described that include measuring at least one effect of a combined bioactive agent and artificial sensory experience on an individual and/or modifying at least one of the bioactive agent or the artificial sensory experience at least partially based on the at least one effect.

Claims

1-86. -86. (canceled)

87. A system, comprising:

an effect measurer module configured to measure at least one effect of a combined bioactive agent and artificial sensory experience on an individual;

a modifier module, including a microprocessor, configured to modify a combination therapy including at least one of an artificial sensory experience or a bioactive agent at least partially based on measuring at least one effect of a combined bioactive agent and artificial sensory experience on the individual.

88. The system of claim 87, wherein the effect measurer module configured to measure at least one effect of a combined bioactive agent and artificial sensory experience on an individual comprises:

a bioactive agent identification acceptor module.

89. The system of claim 87, wherein the effect measurer module configured to measure at least one effect of a combined bioactive agent and artificial sensory experience on an individual comprises:

a substance abuse indication acceptor module.

90. The system of claim 87, wherein the effect measurer module configured to measure at least one effect of a combined bioactive agent and artificial sensory experience on an individual comprises:

a nutraceutical identification acceptor module.

91. The system of claim 87, wherein the modifier module, including a microprocessor, configured to modify a combination therapy including at least one of an artificial sensory experience or a bioactive agent at least partially based on measuring at least one effect of a combined bioactive agent and artificial sensory experience on the individual comprises:

a sensate experience assigner module.

92. The system of claim 91, wherein the sensate experience assigner module comprises:

a stimulus assigner module.

93. The system of claim 87, wherein the modifier module, including a microprocessor, configured to modify a combination therapy including at least one of an artificial sensory experience or a bioactive agent at least partially based on measuring at least one effect of a combined bioactive agent and artificial sensory experience on the individual comprises:

an automated medical device receiver module.

94. The system of claim 87, wherein the modifier module, including a microprocessor, configured to modify a combination therapy including at least one of an artificial sensory experience or a bioactive agent at least partially based on measuring at least one effect of a combined bioactive agent and artificial sensory experience on the individual comprises:

an assigner module configured to assign a virtual world, a modification to a virtual world, a computer game, a modification to a computer game, a website, a modification to a website, an online course, or a modification to an online course.

95. The system of claim 87, wherein the modifier module, including a microprocessor, configured to modify a combination therapy including at least one of an artificial sensory experience or a bioactive agent at least partially based on measuring at least one effect of a combined bioactive agent and artificial sensory experience on the individual comprises:

a monitorer module.

96. The system of claim 87, wherein the modifier module, including a microprocessor, configured to modify a combination therapy including at least one of an artificial sensory experience or a bioactive agent at least partially based on measuring at least one effect of a combined bioactive agent and artificial sensory experience on the individual comprises:

a neurophysiological measurement monitorer module.

97. The system of claim 96, wherein the neurophysiological measurement monitorer module comprises:

a physiologic activity measurer module.

98. The system of claim 87, wherein the modifier module, including a microprocessor, configured to modify a combination therapy including at least one of an artificial sensory experience or a bioactive agent at least partially based on measuring at least one effect of a combined bioactive agent and artificial sensory experience on the individual comprises:

a brain activity surrogate marker measurer module.

99. The system of claim 87, wherein the modifier module, including a microprocessor, configured to modify a combination therapy including at least one of an artificial sensory experience or a bioactive agent at least partially based on measuring at least one effect of a combined bioactive agent and artificial sensory experience on the individual comprises:

a near real time measurer module.

100. The system of claim 87, wherein the modifier module, including a microprocessor, configured to modify a combination therapy including at least one of an artificial sensory experience or a bioactive agent at least partially based on measuring at least one effect of a combined bioactive agent and artificial sensory experience on the individual comprises:

a test function output measurer module.

101. The system of claim 87, wherein the modifier module, including a microprocessor, configured to modify a combination therapy including at least one of an artificial sensory experience or a bioactive agent at least partially based on measuring at least one effect of a combined bioactive agent and artificial sensory experience on the individual comprises:

an effect recorder module.

102. The system of claim 87, further comprising:

a reporter module.

103. The system of claim 102, wherein the reporter module comprises:

a third party reporter module.

104. The system of claim 102, wherein the reporter module comprises:

a compliance data reporter module.

105. The system of claim 102, wherein the reporter module comprises:

a selective reporter module.

106. The system of claim 87, further comprising:

a predictor module.

107. The system of claim 106, wherein the predictor module comprises:

a safety predictor module.

108. The system of claim 106, wherein the predictor module comprises:

a behavioral response predictor module.